Life science investment firm, Medicxi, announced on 7/19/19 that it has closed its Medicxi III fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. The... read more
Life science investment firm, Medicxi, announced on 7/19/19 that it has closed its Medicxi III fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. The... read more
4D Pharma Commences Ph 1/II Asthma Trial
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its... read more
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, announced on 7/16/19... read more
Life science focused Vida Ventures is advancing on its goal of raising $600 million for its second VC fund. According to a recent... read more
Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on... read more